Takashi Kishimoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Takashi Kishimoto has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
Hiroshi Ishikura
Department of Molecular Pathology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
8 shared publicationsYuichiro Nagai
Department of Pathology, National Hospital Organization Chiba Medical Center, 4-1-2, Tsubakimori, Chuo-ku, Chiba 260-8606, Japan
8 shared publicationsMasayuki Ohtsuka
Department of General Surgery, Graduate School of Medicine Chiba University Chuo‐ku Chiba Japan
5 shared publicationsYoshiki Shinomiya
Department of Molecular Pathology, Chiba University Graduate School of Medicine, Chiba, Japan; Department of Pathology, Chiba University Hospital, Chiba, Japan
5 shared publicationsYukio Nakatani
Department of Pathology, Yokosuka Kyosai Hospital, 1-16, Yonegahama-dori, Yokosuka, Kanagawa 238-8558, Japan
5 shared publicationsYusuke Kouchi
Molecular Pathology
5 shared publications
Latest Publications
- 6 February 2026
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
A Case of Ovarian Primary Solid Pseudopapillary Neoplasm With Multiple Organ Metastases
Solid pseudopapillary neoplasm (SPN) is a rare tumor usually arising in the pancreas, while primary ovarian SPN is extremely uncommon. We report a case of ovarian SPN with multi-organ involvement. A woman in her 40s presented with abnormal uterine bleeding and abdominal distension. Imaging revealed a large 20-cm left ovarian mass with liver and lung lesions, but no pancreatic tumor. She underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, and partial omentectomy. The ovarian tumor was well-circumscribed with hemorrhage and necrosis. Histologically, the tumor displayed a solid and pseudopapillary architecture with mild nuclear atypia and prominent vascular invasion. Immunohistochemistry demonstrated nuclear β-catenin and loss of E-cadherin. Genetic analysis confirmed a CTNNB1 exon 3 mutation, while FOXL2 and DICER1 mutations were absent. The findings supported the diagnosis of primary ovarian SPN. The disease progressed with bone and lung metastases despite adjuvant chemotherapy, resulting in the patient’s death 16 mo after surgery. An autopsy was performed, and the absence of a pancreatic tumor was confirmed. This case underscores the diagnostic importance of recognizing ovarian SPN and its potential for aggressive behavior. Awareness of its morphologic, immunophenotypic, and molecular features is essential for distinction from other ovarian tumors.
- 6 February 2026
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
A Case of Ovarian Primary Solid Pseudopapillary Neoplasm With Multiple Organ Metastases
Solid pseudopapillary neoplasm (SPN) is a rare tumor usually arising in the pancreas, while primary ovarian SPN is extremely uncommon. We report a case of ovarian SPN with multi-organ involvement. A woman in her 40s presented with abnormal uterine bleeding and abdominal distension. Imaging revealed a large 20-cm left ovarian mass with liver and lung lesions, but no pancreatic tumor. She underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, and partial omentectomy. The ovarian tumor was well-circumscribed with hemorrhage and necrosis. Histologically, the tumor displayed a solid and pseudopapillary architecture with mild nuclear atypia and prominent vascular invasion. Immunohistochemistry demonstrated nuclear β-catenin and loss of E-cadherin. Genetic analysis confirmed a CTNNB1 exon 3 mutation, while FOXL2 and DICER1 mutations were absent. The findings supported the diagnosis of primary ovarian SPN. The disease progressed with bone and lung metastases despite adjuvant chemotherapy, resulting in the patient’s death 16 mo after surgery. An autopsy was performed, and the absence of a pancreatic tumor was confirmed. This case underscores the diagnostic importance of recognizing ovarian SPN and its potential for aggressive behavior. Awareness of its morphologic, immunophenotypic, and molecular features is essential for distinction from other ovarian tumors.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Pathology
- Vol. 2025 (1)
Intracholecystic Papillary Neoplasm With Associated Invasive Carcinoma, Accompanied by Tumor Thrombi of Hepatoid Adenocarcinoma: A Case Report
Hepatoid adenocarcinoma (HAC) is a rare extrahepatic adenocarcinoma characterized by hepatocellular differentiation. HAC arising in the gallbladder is rare. We report a case of intracholecystic papillary neoplasm (ICPN) with HAC, most of which were tumor thrombi. The patient was a 78‐year‐old Japanese woman diagnosed with a gallbladder mass, detected by ultrasonography. She underwent cholecystectomy with lymph node dissection. Histopathological examination revealed exophytic papillary growth consistent with ICPN with associated invasive carcinoma. Notably, many tumor nests displayed characteristics of HAC, including eosinophilic granular cytoplasm and solid trabecular patterns. Immunohistochemically, tumor cells were positive for AFP, Glypican 3, and Hep Par 1 but negative for SALL4. Our findings underscore the importance of recognizing HAC components in gallbladder lesions, particularly in the context of ICPN with associated invasive carcinoma, as they may significantly impact patient prognosis.
- 1 January 2025
- Published by Wiley in Case Reports in Pathology
- Vol. 2025 (1)
Open AccessIntracholecystic Papillary Neoplasm With Associated Invasive Carcinoma, Accompanied by Tumor Thrombi of Hepatoid Adenocarcinoma: A Case Report
Hepatoid adenocarcinoma (HAC) is a rare extrahepatic adenocarcinoma characterized by hepatocellular differentiation. HAC arising in the gallbladder is rare. We report a case of intracholecystic papillary neoplasm (ICPN) with HAC, most of which were tumor thrombi. The patient was a 78‐year‐old Japanese woman diagnosed with a gallbladder mass, detected by ultrasonography. She underwent cholecystectomy with lymph node dissection. Histopathological examination revealed exophytic papillary growth consistent with ICPN with associated invasive carcinoma. Notably, many tumor nests displayed characteristics of HAC, including eosinophilic granular cytoplasm and solid trabecular patterns. Immunohistochemically, tumor cells were positive for AFP, Glypican 3, and Hep Par 1 but negative for SALL4. Our findings underscore the importance of recognizing HAC components in gallbladder lesions, particularly in the context of ICPN with associated invasive carcinoma, as they may significantly impact patient prognosis.
- 28 October 2024
- Published by Wiley in Pathology International
- Vol. 74 (12) , 691-696
SMARCB1‐deficient malignant neoplasm of the pancreas with heterogeneous morphologies that cannot be classified into existing histologic types
A 50‐year‐old male with a pancreatic tail tumor underwent distal pancreatectomy. At 14 and 27 months after the primary surgery, metachronous liver metastases were identified and partial hepatectomies were performed for each. Pathologic findings of the primary pancreatic tumor were heterogeneous, but they essentially categorized into two components based on their cytologic features: (i) clear cell component and (ii) epithelioid cell component. The metastatic hepatic tumor was entirely composed of the epithelioid cell component. SMARCB1 expression was lost by immunohistochemistry and heterozygous deletion of SMARCB1 was identified by fluorescence in situ hybridization for both the primary and metastatic tumors. Targeted DNA sequencing of a metastatic hepatic tumor sample was performed and SMARCB1 loss was identified. Based on the morphologic, immunohistochemical, and molecular analyzes, the present case was difficult to classify into any of the existing entities. SMARCB1 deficiency might play a key role in the tumorigenesis.
- 28 October 2024
- Published by Wiley in Pathology International
- Vol. 74 (12) , 691-696
SMARCB1‐deficient malignant neoplasm of the pancreas with heterogeneous morphologies that cannot be classified into existing histologic types
A 50‐year‐old male with a pancreatic tail tumor underwent distal pancreatectomy. At 14 and 27 months after the primary surgery, metachronous liver metastases were identified and partial hepatectomies were performed for each. Pathologic findings of the primary pancreatic tumor were heterogeneous, but they essentially categorized into two components based on their cytologic features: (i) clear cell component and (ii) epithelioid cell component. The metastatic hepatic tumor was entirely composed of the epithelioid cell component. SMARCB1 expression was lost by immunohistochemistry and heterozygous deletion of SMARCB1 was identified by fluorescence in situ hybridization for both the primary and metastatic tumors. Targeted DNA sequencing of a metastatic hepatic tumor sample was performed and SMARCB1 loss was identified. Based on the morphologic, immunohistochemical, and molecular analyzes, the present case was difficult to classify into any of the existing entities. SMARCB1 deficiency might play a key role in the tumorigenesis.
- 9 May 2024
- Published by Elsevier in Laboratory Investigation
- Vol. 104 (7) , 102075
Keratin 6A Is Expressed at the Invasive Front and Enhances the Progression of Colorectal Cancer
- 9 May 2024
- Published by Elsevier in Laboratory Investigation
- Vol. 104 (7) , 102075
Keratin 6A Is Expressed at the Invasive Front and Enhances the Progression of Colorectal Cancer
- Open Access
- 13 April 2024
- Published by Wiley in Cancer Science
- Vol. 115 (6) , 1948-1963
ECM1 and KRT6A are involved in tumor progression and chemoresistance in the effect of dexamethasone on pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) has a very poor prognosis. Neoadjuvant chemotherapy is an effective PDAC treatment option, but chemotherapy causes unfavorable side effects. Glucocorticoids (e.g., dexamethasone [DEX]) are administered to reduce side effects of chemotherapy for solid tumors, including pancreatic cancer. Glucocorticoids have both beneficial and detrimental effects, however. We investigated the functional changes and gene‐expression profile alterations induced by DEX in PDAC cells. PDAC cells were treated with DEX, and the cell proliferation, migration, invasion, and chemosensitivity to gemcitabine (GEM) were evaluated. The results demonstrated decreased cell proliferative capacity, increased cell migration and invasion, and decreased sensitivity to GEM. A comprehensive genetic analysis revealed marked increases in ECM1 and KRT6A in DEX‐treated PDAC cells. We evaluated the effects of ECM1 and KRT6A expression by using PDAC cells transfected with those genes. Neither ECM1 nor KRT6A changed the cells’ proliferation, but each enhanced cell migration and invasion. ECM1 decreased sensitivity to GEM. We also assessed the clinicopathological significance of the expressions of ECM1 and KRT6A in 130 cases of PDAC. An immunohistochemical analysis showed that KRT6A expression dominated the poorly differentiated areas. High expressions of these two proteins in PDAC were associated with a poorer prognosis. Our results thus demonstrated that DEX treatment changed PDAC cells’ functions, resulting in decreased cell proliferation, increased cell migration and invasion, and decreased sensitivity to GEM. The molecular mechanisms of these changes involve ECM1 and KRT6A, whose expressions are induced by DEX.
- 13 April 2024
- Published by Wiley in Cancer Science
- Vol. 115 (6) , 1948-1963
Open AccessECM1 and KRT6A are involved in tumor progression and chemoresistance in the effect of dexamethasone on pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) has a very poor prognosis. Neoadjuvant chemotherapy is an effective PDAC treatment option, but chemotherapy causes unfavorable side effects. Glucocorticoids (e.g., dexamethasone [DEX]) are administered to reduce side effects of chemotherapy for solid tumors, including pancreatic cancer. Glucocorticoids have both beneficial and detrimental effects, however. We investigated the functional changes and gene‐expression profile alterations induced by DEX in PDAC cells. PDAC cells were treated with DEX, and the cell proliferation, migration, invasion, and chemosensitivity to gemcitabine (GEM) were evaluated. The results demonstrated decreased cell proliferative capacity, increased cell migration and invasion, and decreased sensitivity to GEM. A comprehensive genetic analysis revealed marked increases in ECM1 and KRT6A in DEX‐treated PDAC cells. We evaluated the effects of ECM1 and KRT6A expression by using PDAC cells transfected with those genes. Neither ECM1 nor KRT6A changed the cells’ proliferation, but each enhanced cell migration and invasion. ECM1 decreased sensitivity to GEM. We also assessed the clinicopathological significance of the expressions of ECM1 and KRT6A in 130 cases of PDAC. An immunohistochemical analysis showed that KRT6A expression dominated the poorly differentiated areas. High expressions of these two proteins in PDAC were associated with a poorer prognosis. Our results thus demonstrated that DEX treatment changed PDAC cells’ functions, resulting in decreased cell proliferation, increased cell migration and invasion, and decreased sensitivity to GEM. The molecular mechanisms of these changes involve ECM1 and KRT6A, whose expressions are induced by DEX.
- 28 March 2024
- Published by Wiley in Pathology International
- Vol. 74 (5) , 292-294
Cystic primary squamous cell carcinoma of the thyroid
- 28 March 2024
- Published by Wiley in Pathology International
- Vol. 74 (5) , 292-294
Cystic primary squamous cell carcinoma of the thyroid
- 23 January 2024
- Published by S. Karger AG in Acta Cytologica
- Vol. 68 (1) , 73-79
Imprint Cytology of Tall Cell Carcinoma with Reversed Polarity of the Breast: A Case Report
Introduction: Tall cell carcinoma with reversed polarity (TCCRP) is a rare histologic subtype of breast cancer that was newly categorized in 2020. TCCRP is a relatively novel tumor, and there are no detailed reports about its cellular morphology. We were able to obtain imprint cytological specimens from fresh TCCRP tissue, and we provide our detailed observations. Case Presentation: The patient was a 73-year-old Japanese female with a 15-mm mass in her right breast. After invasive breast carcinoma was diagnosed based on a core needle biopsy, a lumpectomy was performed. The pathological examination revealed TCCRP, and Sanger sequencing detected IDH2 p.R172M hotspot mutation, which is characteristic of TCCRP. Soon after the surgery, the lumpectomy specimen was sliced before fixation for use in a clinical trial, and imprint cytological materials were obtained from the tumor’s cut surface. Cytologically, the tumor showed papillary-like cell clusters and isolated cells with moderate cellularity. Neoplastic cell aggregates and clusters with thick vascular cores as the axis or with delicate fibrovascular stroma were observed. Most of the neoplastic cells were cuboidal-to-columnar in shape, with mildly to moderately irregularly shaped blunt nuclei. Some intranuclear cytoplasmic inclusions and nuclear grooves were present, resembling the nuclear findings of papillary thyroid carcinoma. The most characteristic finding was the columnar cell clusters with apically located nuclei, giving the impression of reversed polarity. Conclusion: We described cytological findings in TCCRP, a newly classified rare mammary tumor. Most of the characteristic histologic findings were also observed in imprint cytological specimens. Further studies on practical specimens such as fine-needle aspiration are needed for clinical application.
- 23 January 2024
- Published by S. Karger AG in Acta Cytologica
- Vol. 68 (1) , 73-79
Imprint Cytology of Tall Cell Carcinoma with Reversed Polarity of the Breast: A Case Report
Introduction: Tall cell carcinoma with reversed polarity (TCCRP) is a rare histologic subtype of breast cancer that was newly categorized in 2020. TCCRP is a relatively novel tumor, and there are no detailed reports about its cellular morphology. We were able to obtain imprint cytological specimens from fresh TCCRP tissue, and we provide our detailed observations. Case Presentation: The patient was a 73-year-old Japanese female with a 15-mm mass in her right breast. After invasive breast carcinoma was diagnosed based on a core needle biopsy, a lumpectomy was performed. The pathological examination revealed TCCRP, and Sanger sequencing detected IDH2 p.R172M hotspot mutation, which is characteristic of TCCRP. Soon after the surgery, the lumpectomy specimen was sliced before fixation for use in a clinical trial, and imprint cytological materials were obtained from the tumor’s cut surface. Cytologically, the tumor showed papillary-like cell clusters and isolated cells with moderate cellularity. Neoplastic cell aggregates and clusters with thick vascular cores as the axis or with delicate fibrovascular stroma were observed. Most of the neoplastic cells were cuboidal-to-columnar in shape, with mildly to moderately irregularly shaped blunt nuclei. Some intranuclear cytoplasmic inclusions and nuclear grooves were present, resembling the nuclear findings of papillary thyroid carcinoma. The most characteristic finding was the columnar cell clusters with apically located nuclei, giving the impression of reversed polarity. Conclusion: We described cytological findings in TCCRP, a newly classified rare mammary tumor. Most of the characteristic histologic findings were also observed in imprint cytological specimens. Further studies on practical specimens such as fine-needle aspiration are needed for clinical application.
- Open Access
- 9 May 2023
- Published by Springer Nature in Surgical Case Reports
- Vol. 9 (1) , 1-5
Gastric tumor mimicking bronchial tissue associated with a laryngotracheoesophageal cleft: a case report
Background: Laryngotracheoesophageal cleft (LTEC) is a rare disease in which the larynx and trachea communicate posteriorly to the esophagus. It is often associated with other congenital malformations, particularly gastrointestinal anomalies. Herein, we report a case of LTEC associated with a gastric polypoid lesion in bronchial tissue. Case presentation: A gastric mass was detected in a male fetus since week 21 of gestation using fetal ultrasonography. Esophagogastroduodenoscopy performed after birth revealed a pedunculated polypoid lesion of the gastric fornix. The patient experienced frequent vomiting and aspiration pneumonia, which persisted after nasoduodenal tube feeding. Communication between the airway and esophagus was suspected. Laryngoscopy performed 30 days later revealed an LTEC (type III). Partial gastrectomy was performed when the patient was 93 days of age. Histopathological examination revealed tumor consisting of cartilage tissue covered with a layer of respiratory epithelium. Conclusion: The gastric tumor associated with LTEC exhibited structures mimicking bronchial tissue. LTEC occurs because of foregut maldevelopment, and the tumorous respiratory tissue in the stomach may have been formed from the same abnormal foregut development event as LTEC.
- 9 May 2023
- Published by Springer Nature in Surgical Case Reports
- Vol. 9 (1) , 1-5
Open AccessGastric tumor mimicking bronchial tissue associated with a laryngotracheoesophageal cleft: a case report
Background: Laryngotracheoesophageal cleft (LTEC) is a rare disease in which the larynx and trachea communicate posteriorly to the esophagus. It is often associated with other congenital malformations, particularly gastrointestinal anomalies. Herein, we report a case of LTEC associated with a gastric polypoid lesion in bronchial tissue. Case presentation: A gastric mass was detected in a male fetus since week 21 of gestation using fetal ultrasonography. Esophagogastroduodenoscopy performed after birth revealed a pedunculated polypoid lesion of the gastric fornix. The patient experienced frequent vomiting and aspiration pneumonia, which persisted after nasoduodenal tube feeding. Communication between the airway and esophagus was suspected. Laryngoscopy performed 30 days later revealed an LTEC (type III). Partial gastrectomy was performed when the patient was 93 days of age. Histopathological examination revealed tumor consisting of cartilage tissue covered with a layer of respiratory epithelium. Conclusion: The gastric tumor associated with LTEC exhibited structures mimicking bronchial tissue. LTEC occurs because of foregut maldevelopment, and the tumorous respiratory tissue in the stomach may have been formed from the same abnormal foregut development event as LTEC.
- 4 February 2023
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 64, 152110
Complex glandular pattern is an aggressive morphology that predicts poor prognosis of pancreatic ductal adenocarcinoma
- 4 February 2023
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 64, 152110
Complex glandular pattern is an aggressive morphology that predicts poor prognosis of pancreatic ductal adenocarcinoma
- 12 April 2022
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 42 (1) , 78-82
Ovarian Malignant Mixed Germ Cell Tumor Composed Mainly of a Polyembryoma Pattern With Vasculogenic Mesenchymal Tumor Components
Ovarian germ cell tumors composed of numerous well-formed embryonal bodies have been described as exhibiting a “polyembryoma pattern.” In addition, some germ cell tumors are occasionally concomitant with neoplastic vascular proliferation. These include angiosarcomas and the recently reported mediastinal vasculogenic mesenchymal tumors. A 9-yr-old Japanese girl underwent surgery for a right ovarian tumor. Histologically, the polyembryoma pattern, nongestational choriocarcinoma, and vasculogenic lesions characterized by a neoplastic repetition of embryonic vasculogenesis have been intermingled. The polyembryoma pattern consisted of numerous complete and incomplete embryonal bodies and glandular structures resembling adult-type and fetal-type intestines. Vasculogenic lesions were composed of variously developed neoplastic vessels within the myxomatous stroma, which extended well beyond one low-power (40×) microscopic field. We concluded that the vasculogenic lesion in our case was the ovarian counterpart of the mediastinal vasculogenic mesenchymal tumor. After the surgery, the patient was administered adjuvant chemotherapy and was alive with no evidence of recurrence or other malignancy at 28 mo postsurgery.
- 12 April 2022
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 42 (1) , 78-82
Ovarian Malignant Mixed Germ Cell Tumor Composed Mainly of a Polyembryoma Pattern With Vasculogenic Mesenchymal Tumor Components
Ovarian germ cell tumors composed of numerous well-formed embryonal bodies have been described as exhibiting a “polyembryoma pattern.” In addition, some germ cell tumors are occasionally concomitant with neoplastic vascular proliferation. These include angiosarcomas and the recently reported mediastinal vasculogenic mesenchymal tumors. A 9-yr-old Japanese girl underwent surgery for a right ovarian tumor. Histologically, the polyembryoma pattern, nongestational choriocarcinoma, and vasculogenic lesions characterized by a neoplastic repetition of embryonic vasculogenesis have been intermingled. The polyembryoma pattern consisted of numerous complete and incomplete embryonal bodies and glandular structures resembling adult-type and fetal-type intestines. Vasculogenic lesions were composed of variously developed neoplastic vessels within the myxomatous stroma, which extended well beyond one low-power (40×) microscopic field. We concluded that the vasculogenic lesion in our case was the ovarian counterpart of the mediastinal vasculogenic mesenchymal tumor. After the surgery, the patient was administered adjuvant chemotherapy and was alive with no evidence of recurrence or other malignancy at 28 mo postsurgery.